CSL Behring

AFSTYLA

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

CSL Behring

Afstyla HCPCS:

J7210

HCPCS Code Descriptor:

Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.

Category:

J Code

Afstyla NDCs:

69911-0476-02, 69911-0480-02, 69911-0481-02, 69911-0478-02, 69911-0475-02, 69911-0477-02, 69911-0474-02

Primary Type:

Hematology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Afstyla CPT Codes:

Potential CPT administration codes for Afstyla can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Afstyla:

AFSTYLA is a Hematology drug manufactured by CSL Behring and administered via the Intravenous route of administration. The J Code: J7210 is aligned to the drug AFSTYLA.

ACCESS PRICING AND MORE BY REGISTERING

J7210 Added Date:

January 1, 2018

J7210 Effective Date:

January 1, 2018

J7210 Termination Date:

HCPCS Active

Afstyla billing and coding information can be found through Csl Behring at the link below:
Afstyla patient assistance information can be found through AFSTYLA Connect at the URL: https://www.afstyla.com/support
AFSTYLA prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for AFSTYLA. Please check back in a few weeks.